SPPHli004-A 人诱导多能干细胞系 / BioVector® SPPHli004-A Human Induced Pluripotent Stem Cell Line
- 价 格:¥599850
- 货 号:BioVector® SPPHli004-A
- 产 地:北京
- BioVector NTCC典型培养物保藏中心
- 联系人:Dr.Xu, Biovector NTCC Inc.
电话:400-800-2947 工作微信:1843439339 (QQ同号)
邮件:Biovector@163.com
手机:18901268599
地址:北京
- 已注册
BioVector® SPPHli004-A 人诱导多能干细胞系 / BioVector® SPPHli004-A Human Induced Pluripotent Stem Cell Line
通用定义 / General Definition:
BioVector® SPPHli004-A 是一种人源诱导多能干细胞 (iPSC) 系,它是 SPPHli 系列标准化细胞株中的重要成员。该细胞系由健康供体的体细胞通过非整合重编程技术(通常为塞内卡病毒或游离质粒)建立。SPPHli004-A 具有典型的人多能干细胞特征,能够无限自我更新,并在特定诱导条件下分化为体内任何类型的细胞。该细胞系经过严格的质量控制,包括核型分析、多能性标志物检测及三胚层分化能力验证,常作为生物医学研究中的标准对照株或分化研究的基础模型。
BioVector® SPPHli004-A is a human Induced Pluripotent Stem Cell (iPSC) line, a key member of the standardized SPPHli series. This line was established from somatic cells of a healthy donor using non-integrative reprogramming technologies (typically Sendai virus or episomal vectors). SPPHli004-A exhibits classic human pluripotent stem cell characteristics, capable of infinite self-renewal and differentiation into any cell type of the human body under specific inductive conditions. The line undergoes rigorous quality control, including karyotyping, pluripotency marker testing, and tri-lineage differentiation validation, serving as a standard control line or a foundational model for differentiation studies in biomedical research.
BioVector® SPPHli004-A 技术说明书 (Technical Datasheet)
中文版说明书 (Chinese Datasheet)
1. 产品基本信息
产品名称: BioVector® SPPHli004-A 人 iPSC 细胞系
供体背景: 健康供体,具有明确的性别及年龄背景资料。
重编程方式: 非整合型(Non-integrative),无病毒基因组残留。
质量鉴定: 已通过 $G$-带核型扫描(46, XX 或 46, XY)以及无支原体检测。
生长特性: 贴壁生长,在优质基质上形成边缘清晰、细胞致密的集落。
2. 培养条件
基础培养体系: BioVector® mTeSR Plus 或同类无蛋白/无喂养层培养基。
包被材料:Matrigel (基质胶) 或重组人 Laminin-511。
培养环境: 37 摄氏度,5% $CO_2$。
传代策略: 推荐使用 0.5 mM EDTA 进行离解,采用小集群传代(Small Clumps),传代比例通常为 1:6 至 1:10。
3. 细胞应用
遗传学研究: 作为对照组,评估疾病相关突变对细胞功能的影响。
细胞治疗探索: 研究多能干细胞向临床相关细胞类型(如心肌、神经、造血)的分化效率。
高通量筛选: 用于药物发现过程中早期的人源毒性测试和药效评估。
4. 注意事项
分化风险: 若集落中心出现空洞或边缘出现分化的成纤维样细胞,需立即进行手工清理(Scraping)。
储存: 长期储存于液氮气相($-150$ 摄氏度以下)。
English Datasheet
1. General Product Information
Product Name: BioVector® SPPHli004-A Human iPSC Line
Donor Profile: Derived from a healthy donor; comprehensive demographic data available.
Reprogramming Method: Non-integrative technology, ensuring the host genome remains free of vector sequences.
Quality Control: Validated via $G$-banded karyotyping (46, XX or 46, XY) and mycoplasma-free certification.
Growth Properties: Adherent; forms dense colonies with distinct borders on high-quality substrates.
2. Culture Conditions
Culture System: BioVector® mTeSR Plus or equivalent protein-free/feeder-free media.
Coating Substrate:Matrigel or recombinant human Laminin-511.
Incubation: 37 degrees Celsius, 5% $CO_2$.
Subculturing: Recommended dissociation using 0.5 mM EDTA for small clump passaging; typical split ratios range from 1:6 to 1:10.
3. Applications
Genetic Research: Serving as a baseline control to evaluate the impact of disease-related mutations on cellular phenotypes.
Cell Therapy Development: Investigating the differentiation efficiency into clinically relevant lineages (e.g., cardiomyocytes, neurons, hematopoietic cells).
High-Throughput Screening: Utilized for early-stage human-derived toxicity testing and efficacy evaluation in drug discovery.
4. Key Usage Notes
Differentiation Management: Monitor daily. If hollow centers or fibroblastic-like cells appear at colony edges, perform manual scraping to maintain culture purity.
Cryopreservation: Store in the vapor phase of liquid nitrogen (below $-150$ degrees Celsius) for long-term viability.
注意 / Note: BioVector® SPPHli004-A 应在生物安全二级 (BSL-2) 条件下操作。该细胞系是构建等基因对照 (Isogenic Controls) 的理想母本。在进行基因组编辑时,建议配合 BioVector® 专用转染试剂盒以提高成功率。
BioVector® SPPHli004-A should be handled under Biosafety Level 2 (BSL-2) conditions. This line is an ideal parental candidate for generating isogenic controls. For genomic editing, BioVector® recommends using specialized transfection kits to optimize efficiency.
BioVector NTCC质粒载体菌株细胞蛋白抗体基因保藏中心
电话:400-800-2947
工作QQ/微信同号:1843439339
网址
- 公告/新闻




